Monthly Archives:

The Scherzer Deal Report: July 24-30, 2020


Here is this week’s Deal Report for private equity and venture capital activity for US-based PE and VC firms and portfolio companies, brought to you by Scherzer International.


PE and VC Firms Fundraising Location Amount Description
Adams Street Partners Chicago, IL $1.1B New private credit fund
Gallant Capital Los Angeles, CA $378M Debut fund


Private Equity Investors Company  Amount Description
WindRose Health Investors Caregiver Undisclosed Fort Worth, TX-based provider of long-term care services to people with intellectual and developmental disabilities
Gemspring Capital Cforia Software Undisclosed Westlake Village, CA-based provider of order-to-cash automation software
Clayton, Dubilier & Rice  Cheney Bros Undisclosed Family-owned food distributor serving the Southeastern United States
Tenex Capital Management Consolidated Label Undisclosed Sanford, FL-based provider of custom-printed, pressure-sensitive labels and shrink sleeves
Berkshire Partners CrossFit Undisclosed Washington, DC-based fitness brand
TA Associates and Francisco Partners Edifecs Undisclosed Bellevue, WA-based provider of health care IT solutions
Core Industrial Partners Incodema Undisclosed Merger of Incodema – an Ithaca, NY-based precision sheet metal engineering firm, and Newchem, a Newark, NY-based photo chemical etching manufacturer
Crestview Partners Upwell Water Undisclosed San Francisco, CA-based specialty finance firm focused on the water market
TowerBrook Capital Partners Validity Finance $100M New York-based commercial litigation firm


Venture Capital Investors Company  Amount Description
MSD Partners BioTheryX $35M San Diego, CA-based biotech focused on restoring protein homeostasis
Versant Ventures Bright Peak Therapeutics $35M San Diego, CA-based biotech focused on chemically synthesizing and optimizing proteins
Pitango Growth, Square Peg Capital ClimaCell $23M Boston, MA-based weather intelligence platform
Kleiner Perkins, 01 Advisors, Upfront Ventures, Founders Fund, Ludlow Ventures, Launch, DTA, Alex Rodriguez, LBC Ventures, Julia and Kevin Hartz, Cyan and Scott Banister Density $51M San Francisco, CA-based startup that measures indoor headcount
Gilde Healthcare, Longitude Capital, NEA, the Charles and Helen Schwab Foundation, Nan Fung Life Sciences Eargo $71M San Jose, CA-based medical device startup focused on hearing loss
Accel, Glilot Capital Partners, Norwest Venture Partners, Target Global Ermetic $17.3M Palo Alto and Tel Aviv-based cloud access risk security startup
Zeev Ventures, Dynamic Loop, Emerge, F2 Capital Explorium $31M San Mateo, CA-based data science startup
PXV Fund, Drive Capital Forge Biologics $40M Columbus, OH-based viral vector gene therapy startup
Kayne Partners, 8VC, Fontinalis Partners, Revolution Ventures, Hearst Ventures, Prologis Ventures, Story Ventures, Engage Ventures FreightWaves $37M Chattanooga, TN-based freight data startup
CPT Capital, WTT Investment Geltor $91.3M San Leandro, CA-based animal-free “ingredients-as-a-service” startup
Humana Heal $100M Los Angeles, CA-based physician house call and telemedicine platform
Canaan Partners, Stanford StartX, Root Ventures, Eclipse Ventures, First Round Capital Instrumental $20M Palo Alto, CA-based computer vision startup focused on detecting manufacturing anomalies
Frazier Healthcare Partners, OrbiMed, NEA, IU PhV, BioCrossroads, Twilight Venture Partners MBX Biosciences $34.6M Carmel, IN-based biotech focused on rare endocrine diseases
Argentum, Breakwater Mediant, Compo Seven Capital, Mathers Associates, First Analysis Corp Mediant $18.5M New York-based investor communications platform
The Column Group, Samsara BioCapital, Euclidean Capital Nura Bio $73M San Francisco, CA-based developer of neuroprotective drugs
Flagship Pioneering Omega Therapeutics $85M Cambridge, MA-based epigenomics startup
Eventide Asset Management, Avoro Capital, Surveyor Capital, Point72, Cormorant, Qatar Investment Authority, Irving Investors, Adage Capital Management, Verition Fund Management, Ample Plus Fund, Vida Ventures, Novo Holdings, Blackstone Life Sciences, OCV Partners Praxis Precision Medicines $110M Cambridge, MA-based biotech focused on CNS disorders
Energy Impact Partners, Paladin Capital Group, Cisco Investments Rangeforce $16M Manassas, VA-based cybersecurity training startup
PayU, DN Capital, Generation Investment Management, Owl Rock Capital, Princeville, Stripes, Threshold Ventures, Top Tier Capital Remitly $85M Seattle, WA-based digital remittance company
General Catalyst, The Chernin Group, FirstMark Capital, Torch, SignalFire, TQ Ventures, Initialized Capital, 3L, BoxGroup Ro $200M New York-based DTC pharmacy focused on men’s health
BlackRock, Deerfield Management, Moore Capital Sema4 $120M Stamford, CT-based health intelligence company
GIC, Silver Lake Waterman, Andreessen Horowitz, Index Ventures, Spark Capital, USV Stack Overflow $85M New York, NY-based coding Q&A site
Norwest Venture Partners, General Catalyst Tempo $60M Connected home gym startup
Casdin Capital, Section 32, Bain Capital Life Sciences, Brown Advisory, Driehaus Capital, Intermountain Ventures, Janus Henderson Investors, Lux Capital, Moore Strategic Ventures, Perceptive Advisors, Rock Springs Capital, Sands Capital, T. Rowe Price Thrive Earlier Detection $257M Cambridge, MA-based early cancer detection startup
Khosla Ventures, Centana Growth Partners True Link Financial $35M San Francisco, CA-based provider of digital financial services targeting retirees
CoVenture, GPS Partners, Golden Ventures, Sweet Capital Wave.tv $32M Los Angeles, CA-based interactive sports media platform

Client Alert: EU Court of Justice Invalidates the EU-US Privacy Shield

An important and unexpected ruling was handed down by the Court of Justice of the European Union (CJEU) on July 16, 2020, in Data Protection Commissioner v Facebook Ireland Ltd and Maximillian Schrems (“Schrems II”) that invalidates the EU-U.S. Privacy Shield (“Privacy Shield”) arrangement. Since 2016, the Privacy Shield provided U.S. companies with a mechanism to comply with the General Data Protection Regulation (GDPR) requirements when transferring personal data from the European Union to the U.S.

What this means

Now companies that subscribed to the Privacy Shield must find another GDPR-compliant solution for the transfer of data. The European Data Protection Board indicated in its July 23, 2020 FAQs that it will not be providing a grace period as the authorities had done for the EU-U.S. Safe Harbor (“Safe Harbor”) framework following the “Schrems I” decision.

Notably, the CJEU’s decision expressly stated that the standard contractual clauses (SCCs) previously promulgated by the European Commission (EC) are still a valid tool for data transfers from the EU to the United States. The SCCs are sets of contractual terms and conditions that the controller and the processor of the data both execute to comply with GDPR’s requirements.  However, the CJEU’s decision does not give blanket approval to the SCCs–the decision acknowledged that future challenges to SCCs are permissible by the local data enforcement agency for any EU-member state. For example, an EU-member state might prohibit or suspend exports of personal data from its country under SCCs, if the member state concludes that the SCCs are not or cannot be complied with in the recipient third country (such as the U.S.) because of the member state’s local legal requirements.

The CJEU did not directly reference binding corporate rules (‘BCRs’) which are used for intragroup data transfers and require prior approval of the competent data protection authority. For now, this means that BCRs remain a valid transfer mechanism under the GDPR as BCRs are of a similar nature to  SCCs (both are considered an “appropriate safeguard” pursuant to Article 46 GDPR).

For some situations, an alternative is to look to the narrow derogations under Article 49 of the GDPR, such as to perform a contract or base the transfer on the subject’s explicit consent.  

What happens next

When the adequacy of the Safe Harbor was invalidated by the CJEU in 2015, the U.S. Department of Commerce (DOC) and the EC had already been negotiating for an updated trans-Atlantic program for many months. With Schrems II, and although the DOC and EC have indicated that lines of communication are open, the discussions are not nearly as advanced. And the issues cited by the CJEU in Schrems II may require some form of legislative and not merely an administrative action to address. As such, the process to revamp the Privacy Shield is unlikely to be concluded any time soon.  

The DOC, in a press release in response to the CJEU’s decision, and later in its updated Privacy Shield FAQs, stated that it will continue to administer the Privacy Shield program, including processing submissions for self-certification and re-certification and maintaining the participants’ list. The DOC emphasized that the CJEU’s decision “does not relieve participating organizations of their Privacy Shield obligations.”

The UK’s Data Enforcement Agency also issued a statement advising companies to continue using the Privacy Shield until new guidance becomes available but added that companies “do not start using the Privacy Shield during this period.”

Stay tuned for more regulatory guidance and other developments in the next few weeks.


Disclaimer: This is not legal advice. The resources and information provided here are for educational purposes only. Consult your own counsel if you have legal questions related to your specific practices and compliance with applicable laws.

The Scherzer Deal Report: July 8-14, 2020


Here is this week’s Deal Report for private equity and venture capital activity for US-based PE and VC firms and portfolio companies, brought to you by Scherzer International.


PE and VC Firms Fundraising Location Amount Description
Actis London, UK $2.9B Fifth renewable energy fund
DCM Menlo Park, CA $880M Tenth fund
Engineering Capital Palo Alto, CA $60M Third fund
Navegar Philippines $197M Second fund
The Blackstone Group New York, NY $4.6B Debut life sciences fund
TrueBridge Capital Partners Chapel Hill, NC $600M Sixth VC fund-of-funds


Private Equity Investors Company  Amount Description
HgCapital  F24 Undisclosed Pan-European emergency notification provider
Madison Dearborn Partners Benefytt Technologies $410M Tampa, FL-based health insurance tech provider
Sonoma Brands Chef’s Cut Real Jerky Co. Undisclosed New York-based meat snacks brand
KKR  Global Atlantic Financial Group $4.4B Bermuda-based retirement and life insurance company
Round Table Capital Partners Hull & Associates Undisclosed Midwest and Mid-Atlantic-based environmental and engineering consultancy
KCM Capital Partners Mason West Undisclosed Placentia, CA-based provider of engineered seismic restraint and vibration isolation products
H.I.G. Capital Project Informatica Undisclosed Italian IT consultant
Parthenon Capital RxSense Undisclosed Boston, MA-based provider of prescription savings solutions to consumers and pharmacy benefits administrators
Align Capital Partners WilliamsMarston Undisclosed Boston and New York an accounting advisory and management consulting firm


Venture Capital Investors Company  Amount Description
T. Rowe Price, Pinnacle Bank Apiture $20M Digital banking experience startup
General Atlantic Doctor On Demand $75M San Francisco, CA-based virtual care provider
S2G Ventures, Cox Enterprises, Skyline Global Partners, Bunge Ventures, Finistere Ventures Growers Edge $40M Johnston, IA-based provider of fintech products for farmers
Hudson Bay Capital, OrbiMed, Country Garden VC, GTJA Investment Group, Octagon Capital, Sage Partners Harbour BioMed $103M Massachusetts and China-based cancer drug startup
Two Bear Capital Inimmune $22M Missoula, MT-based developer of adjuvants for vaccines
Undisclosed Karma Automotive $100M Reincarnation of electric carmaker Fisker Auto
General Catalyst, Khosla Ventures, Eldridge, Manta Ray Ventures, Tiny Blue Dot, Johnson Kernel $53M Los Angeles, CA-based neuroscience startup
Perceptive Advisors, RRE, GV, Freemark Capital Kindbody $32M New York-based provider of women’s fertility services,
Emergence Capital, TI Platform Management, Radianx Capital, Top Tier Capital, Trend Forward Capital, Initialized Capital, Providence Equity LogDNA $25M Mountain View, CA-based startup focused on simplify server data logging
Volition Capital,  Greycroft, Horsley Bridge, Lerer Hippeau Medly Pharmacy $100M New York-based digital pharmacy
ABB Technology Ventures, NanoDimension Capital, Volta Energy Technologies, Chevron, Khosla Ventures, Prelude Ventures Natron Energy $35M Santa Clara, CA-based developer of sodium-ion batteries
The Blackstone Group , Howard Schultz, Oprah Winfrey, Roc Nation, Natalie Portman, Orkila Capital, Rabo Corporate Investments Oatly $200M Swedish oat milk company
Goldman Sachs Merchant Banking, Healthcare Venture Partners Paige $70M New York-based computational pathology startup
CPP Investments, Temasek, Horizons Ventures Perfect Day $160M Animal-free dairy
T. Rowe Price, Soros Fund Management, Fidelity, Baron Capital, Amazon, BlackRock Rivian $2.5B Plymouth, MI-based electric truck-maker
TSG Consumer Partners, IVP Robinhood $320M No-fee digital brokerage
Next47,  Levitate Capital, NTT Docomo Ventures, Andreessen Horowitz, IVP, Playground VC Skydio $100M Redwood City, CA-based autonomous drone developer
Ping An, JPMorgan, Prosperity7 Ventures, Zouk Ventures Taulia $60M San Francisco, CA-based B2B payments platform
CIC Partners, Morgan Stanley Expansion Capital, Dirk Nowitzki, Kendra Scott Tiff’s Treats $15M Austin, TX-based warm cookie delivery brand
Remiges Ventures, SR One, Vivo Capital, Hillsborough Venture, Correlation Ventures Tranquis Therapeutics $30M San Mateo, CA-based immuno-neurology startup
TI Platform Fund, Optum Ventures, Initialized Capital, Sound Ventures Truepill $25M San Mateo, CA-based digital pharmacy startup
Alkeon, Accel, Coatue, Dragoneer, IVP, Madrona Venture Group, Sequoia Capital, Tencent, Tiger Global, Wellington, T. Rowe Price UiPath $225M New York-based developer of robotic process automation software
Matrix Capital Management, Surveyor Capital, Adage Capital, Cormorant Asset Management, Farallon, Foresite Capital, Janus Henderson, Logos Capital, OrbiMed, T. Rowe Price, Venrock, Viking Global Investors, Wellington Management, Arix Bioscience, Decheng Capital, Pappas Capital, Sofinnova Ventures, Takeda Ventures VelosBio $137M San Diego, CA-based developer of antibody drug conjugates to treat cancers
Walgreens Boots Alliance VillageMD $1B Chicago, IL-based primary health care provider
RA Capital Management, Fidelity, Pagliuca Family Office, Alexandria Venture Investments, 5AM Ventures, Johnson & Johnson Innovation, Osage University Partners, PureTech Health Vor Biopharma $110M Cambridge, MA-based engineered cell therapy startup

Go to Top